Skip to main content
. 2011 Mar 15;203(6):814–822. doi: 10.1093/infdis/jiq116

Table 1.

Baseline Characteristics of Women Whose Human Papillomavirus (HPV) Infections Cleared versus Those Whose HPV Infections Persisted

Clearance
Persistence
Enrollment (n = 678) (n = 58) P
Smoking
    Never 603 (88.9) 46 (79.3) .002
    Former 26 (3.8) 9 (15.5)
    Current 49 (7.2) 3 (5.2)
Oral contraceptive use
    Missing 1 (0.1) 0 (0.0) <.001
    Never 214 (31.6) 38 (65.5)
    Former 299 (44.1) 16 (27.6)
    Current 164 (24.2) 4 (6.9)
Parity
    0-1 67 (9.9) 4 (6.9) <.001
    2 265 (39.1) 10 (17.2)
    3-5 173 (25.5) 7 (12.1)
    ≥6 173 (25.5) 37 (63.8))
Age at first sexual experience
    <16 165 (24.3) 16 (27.6) .5
    16 91 (13.4) 5 (8.6)
    17-18 212 (31.3) 15 (25.9)
    ≥19 210 (31.0) 22 (37.9)
Lifetime no. of sex partners
    1 238 (35.1) 26 (44.8) .007
    2-3 266 (39.2) 27 (46.6)
    ≥4 174 (25.7) 5 (8.6)
Recent no. of sex partners
    0-1 635 (93.7) 56 (96.6) .6
    ≥2 43 (6.3) 2 (3.4)
Income, Colones
    Missing 31 (4.6) 8 (13.8) <.001
    <15,000 152 (22.4) 26 (44.8)
    15,000 to <25,000 187 (27.6) 9 (15.5)
    25,000 to <35,000 133 (19.6) 5 (8.6)
    ≥35,000 175 (25.8) 10 (17.2)
Marital status at baseline
    Married or living together 476 (70.2) 36 (62.1) .2
    Divorced, separated, widowed, or single 202 (29.8) 22 (37.9)
HPV infections at baseline
    Single 398 (58.7) 21 (36.2) .001
    Multiple 280 (41.3) 37 (63.8)

NOTE. Data are no. (%) of subjects, unless otherwise indicated. Kruskal-Wallis tests were used to test for differences between viral outcomes for continuous variables, Fisher's exact tests were used for two category variables, and Pearson's chi-square for were used for three or more category variables.